Journal of Genetic Engineering and Biotechnology (Dec 2017)

Serum apelin levels and metabolic risk markers in obese women

  • Moushira Zaki,
  • Sanaa Kamal,
  • Wafaa Ezzat,
  • Naglaa Hassan,
  • Walaa Yousef,
  • Hanaa Ryad,
  • Ramy Mohamed,
  • Eman Youness,
  • Walaa Basha,
  • Yasser Elhosary

DOI
https://doi.org/10.1016/j.jgeb.2017.05.002
Journal volume & issue
Vol. 15, no. 2
pp. 423 – 429

Abstract

Read online

Background: Adipose tissue hormones, Adipokines, play an important role in obesity-associated complications. Apelin has recently been added to the family of adipokines. The aim of this study was to evaluate the relationship between serum apelin levels and metabolic abnormal parameters in Egyptian obese women. Materials and methods: The study included 400 unrelated women; they were 200 obese women and 200 non- obese matched healthy women. All participants underwent clinical, anthropometric and biochemical examinations. Insulin resistance (IR) was determined by the homeostasis model assessment of insulin resistance (HOMA-IR). Serum apelin levels and obesity biomarkers were measured using enzyme-linked immunoassay (ELISA) kits. Fat mass was measured by Tanita Body Composition Analyzer. Results: Obese women showed significant higher levels of serum apelin, leptin, triglycerides, LDL-C, total cholesterol, fasting insulin HOMA-IR and blood pressure levels than controls. Significant positive correlations between apelin and leptin levels with abnormal metabolic markers were noted in obese women. Conclusion: The present study suggests the significant role that might be mediated by apelin for developing abnormal metabolic parameters among Egyptian obese women.

Keywords